Schaefflertanz Corporation

COVARREST

Therapeutic pharmaceutical for the treatment of infectious disease, including COVID-19;Research and development in the pharmaceutical and biotechnology fields relating to infectious disease, including COVID -19; pharmaceutical research and development relating to infectious disease, including COVID -19; scientific research and development relating to infectious disease, including COVID -19;

COVASSESS

Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents and assays for testing of body fluids; all of the foregoing related to infectious disease, including Covid-19;Medical services, namely, the treatment of infectious disease through the use of diagnostic testing to determine key susceptibilities to identified viruses and a course of therapeutics and pharmaceutical preparations in accordance with said susceptibilities; all of the foregoing related infectious disease, including Covid-19;

COVATEST

Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, infectious disease; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents and assays for testing of body fluids; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of infectious diseases; all of the foregoing relating to infectious disease, including COVID -19;COVA TEST; COVID TEST; COV ATTEST;Medical diagnostic testing, monitoring and reporting services; Medical testing for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of infectious disease; all of the foregoing relating to infectious disease, including COVID -19;Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; Medical diagnostic apparatus for testing DNA and RNA samples; Medical diagnostic apparatus for testing for viruses; Medical diagnostic apparatus for testing DNA and RNA samples; Medical diagnostic apparatus for testing of nucleic acids; all of the foregoing relating to infectious disease, including COVID -19;Research and development and consultation related thereto in the field of infectious disease testing; Research and development in the field of infectious disease testing; Research and development of technology in the field of infectious disease testing; Research and development services in the field of antibodies; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific research and development; all of the foregoing relating to infectious disease, including COVID -19;

COVINNOVATIONS

Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, infectious disease, including COVID-19; Medical diagnostic reagents and assays for testing body fluids for microorganisms relating to infectious disease, including COVID-19; Medical diagnostic reagents and assays for testing of body fluids relating to infectious disease, including COVID-19; Therapeutic pharmaceutical for the treatment of infectious disease, including COVID-19; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids relating to infectious disease, including COVID-19; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of infectious disease, including COVID-19;Medical diagnostic testing, monitoring and reporting services relating to infectious disease, including COVID-19; Medical services, namely, the treatment of infectious disease through the use of diagnostic testing to determine key susceptibilities to identified viruses, including COVID-19, and a course of therapeutics and pharmaceutical preparations in accordance with said susceptibilities; Medical testing for diagnostic or treatment purposes relating to infectious disease, including COVID-19; Medical testing for diagnostic or treatment purposes in the field of infectious disease, including COVID-19;Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing of infectious disease, including COVID-19; Medical diagnostic apparatus for testing DNA and RNA samples for infectious disease, including COVID-19; Medical diagnostic apparatus for testing for viruses, including COVID-19; Medical diagnostic apparatus for testing DNA and RNA samples for infectious disease, including COVID-19; Medical diagnostic apparatus for testing of nucleic acids for infectious disease, including COVID-19;Research and development and consultation related thereto in the field of infectious disease, including COVID-19 testing; Research and development in the field of infectious disease, including COVID-19 testing; Research and development in the pharmaceutical and biotechnology fields, relating to infectious disease, including COVID-19; Research and development of technology in the field of infectious disease, including COVID-19 testing; Research and development services in the field of antibodies relating to infectious disease, including COVID-19; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines relating to infectious disease, including COVID-19; Scientific research and development relating to infectious disease, including COVID-19; Pharmaceutical research and development relating to infectious disease, including COVID-19;

COVINNOVATIONS

COVINNOVATIONS; CO INNOVATIONS;Licensing of intellectual property;